Elanco joins FD community
12 Feb 2017
Another major player in the animal medicine industry arrived in Fort Dodge in January.
Elanco U.S. Inc. purchased the manufacturing and research complex at 800 Fifth St. N.W. and the product lines made there from Boehringer Ingelheim Vetmedica Inc. for $885 million.
The new owner, which is a part of pharmaceutical giant Eli Lilly and Co., took over the site on Jan. 27.
“As a result of the acquisition, Elanco will bring greater value to customers by providing a suite of options for preventing common diseases in companion animals,” John C. Lechleiter, the chairman, president and chief executive officer of Eli Lilly and Co., said in a statement announcing the purchase.
“Coupled with our robust food animal portfolio, this addition further strengthens Elanco’s position in the global animal health business,” he added.
Elanco U.S. Inc., based in Greenfield, Indiana, plans to retain all of the plant’s roughly 500 workers.
The purchase was welcomed by local officials.
“We’re excited to work with our new partner in Elanco,” Fort Dodge Mayor Matt Bemrich said.
Bemrich said the community developed a good relationship with Boehringer Ingelheim Vetmedica Inc.
“We’re sad to see them go, but we’re excited to start a new page in the book with Elanco,” he said.
Webster County Supervisor Merrill Leffler described the deal as “a sign of good things happening around the county and good things to come.”
Boehringer Ingelheim Vetmedica Inc. executives announced in April 2016 that the plant would be sold to meet regulatory requirements imposed on a deal between it and another company.